Baloxavir marboxil showed superiority over placebo and similar efficacy to oseltamir in reducing influenza symptoms.
John Parkinson
Advertisement
John Parkinson is the assistant managing editor for Contagion. Prior to joining MJH Life Sciences in 2020, he has covered a variety of fields and markets including diabetes, oncology, ophthalmology, IT, travel, and local news. You can email him at jparkinson@mjhlifesciences.com.
Articles by John Parkinson
Early administration of such therapies in this patient group not shown to help mortality rates.
An assessment of 21 pediatric cases leads France investigators to believe development is due to post-viral immunological reactions.
Advertisement
Advertisement
Advertisement
Trending on Contagion Live
1
Nearly 1 in 5 Urinary Tract Infections in Southern California Linked to Contaminated Meat
2
Moderna Discontinues Development of Vaccine for Congenital CMV After Not Meeting Primary Efficacy Endpoint
3
High Continued Adherence of Lenacapavir in Individuals Who Use Substances and Alcohol
4
Risk Stratification, Testing, and Treatment in Recurrent Clostridioides difficile
5
